References
- JinnoJOhDMCrisonJRAmidonGLDissolution of ionizable water-insoluble drugs: The combined effect of pH and surfactantInt J Pharm200089268274
- MihalicMPiroxicamAnalytical Profiles of Drug Substances19861523
- RobertsMSCrossSEPercutaneous absorption of topically applied NSAIDs and other compounds: Role of solute properties, skin physiology and delivery systemsInflammopharmacology1999733935017657437
- GoosenCPlessisJDMüllerDGJanse van RensburgLFCorrelation between physicochemical characteristics, pharmacokinetic properties and transdermal absorption of NSAIDsInt J Pharm1998163203209
- BeetgeEPlessisJDMüllerDGGoosenCvan RensburgFJThe influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAIDs on their transdermal absorptionInt J Pharm200019326126410606790
- HadgraftJPlessisJDGoosenCThe selection of non-steroidal anti-inflammatory agents for dermal deliveryInt J Pharm2000207313711036227
- CheongHAChoiHKEnhanced percutaneous absorption of piroxicam via salt formation with ethanolaminesPharm Res2002191375138012403076
- HuangYBWuPCKoHMTsaiYHEffect of pretreatment by cardamom oil on in vivo percutaneous absorption of piroxicam gel: Pharmacokinetic analysis in rabbitsInt J Pharm1996134183191
- HsuLRTsaiYHHuangYBThe effect of pretreatment by penetration enhancers on the in vivo percutaneous absorption of piroxicam from its gel form in rabbitsInt J Pharm199171193200
- SantoyoSArellanoAYgartuaPMartinCPenetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skinInt J Pharm1995117219224
- SantoyoSYgartuaPEffect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical applicationEur J Pharm Biopharm20005024525010962234
- PénzesTBlazsóGAignerZFalkayGErosITopical absorption of piroxicam from organogels – in vitro and in vivo correlationsInt J Pharm2005298475415893893
- ShinSCChoCWOhIJEnhanced eff icacy by percutaneous absorption of piroxicam from the poloxamer gel in ratsInt J Pharm200019321321810606784
- CurdyCKaliaYNNaikAGuyRHPiroxicam delivery into human stratum corneum in vivo: Iontophoresis versus passive diffusionJ Control Release200176737911532314
- KreilgaardMInfluence of microemulsions on cutaneous drug deliveryAdv Drug Deliv Rev200254S779812460717
- KengPSBasriaMZakariaMRSNewly synthesized palm esters for cosmetics industryInd Crops Prod2009293744
- AbdulkarimMFAbdullahGZChitneniMFormulation and characterization of palm oil esters based nano-cream for topical delivery of piroxicamInt J Drug Deliv20102287298
- AbdulkarimMFAbdullahGZChitneniMStability studies of nano-cream containing piroxicamInt J Drug Deliv20102333339
- DjordjevicJMichniakBUhrichKEAmphiphilic star-like macromolecules as novel carriers for topical delivery of non-steroidal anti-Inflammatory drugsAAPS PharmSciTech20035112
- NgSFRouseJSandersonDEcclestonGAComparative study of trans-membrane diffusion and permeation of ibuprofen across synthetic membranes using Franz diffusion cellsPharmaceutics20102209223
- ÖzgüneyISKarasuluHYKantarcGSözerSGüneriTErtanGTransdermal delivery of diclofenac sodium through rat skin from various formulationsAAPS PharmSciTech200674E1716584139
- SinghSGajraBRawatMMuthuMSEnhanced transdermal delivery of ketoprofen from bioadhesive gelsPak J Pharm Sci20092219319819339232
- WagnerHKostkaKHLehrCMSchaeferUFInterrelation of permeation and penetration parameters obtained from in vitro experiments with human skin and skin equivalentsJ Control Release20017528329511489316
- LarsonDLLombardinoJGThe topical anti-inflammatory effects of piroxicam in rodentsAgents Actions1980102462527405751
- YamMFLimVSalmanIMHPLC and anti-inflammatory studies of the flavonoid rich chloroform extract fraction of Orthosiphon stamineus leavesMolecules2010154452446620657453
- YamMFAngLFAmeerOZSalmanIMAzizHAAsmawiMZAnti-inflammatory and analgesic effects of Elephantopus tomentosus ethanolic extractJ Acupunct Meridian Stud2009228028720633503
- GuyRHHadgraftJOn the determination of drug release rates from topical dosage formsInt J Pharm199060R13
- ShahVPElkinsJLamSYSkellyJPDetermination of in vitro drug release from hydrocortisone creamsInt J Pharm1989535359
- DalmoraMEDalmoraSLOliveiraAGInclusion complex of piroxicam with beta-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effectInt J Pharm2001222455511404031
- GuptaPKCannonJBLiuREmulsion and micro-emulsion for drug solubilization and deliveryWater-insoluble Drug FormulationNew York, NYCRC Press2000
- ChenHChangXDuDLiJXuHYangXMicroemulsion-based hydrogel formulation of ibuprofen for topical deliveryInt J Pharm2006315525816600540
- AbdullahGZAbdulkarimMFChitneniMPreparation and in vitro evaluation of mebeverine HCl colon-targeted drug delivery systemPharm Dev Technol4302010 [Epub ahead of print]
- ProniukSBlanchardJAnhydrous Carbopol® polymer gels for the topical delivery of oxygen/water sensitive compoundsPharm Dev Technol2002724925512066579
- WesterRCNoonanPKRelevance of animal models for percutaneous absorptionInt J Pharm1980799110
- NaikAKaliaYNGuyRHTransdermal drug delivery: Overcoming the skin’s barrier functionPharm Sci Technolo Today2000331832610996573
- WaltersKARobertsMSWaltersKAHadgraftJVeterinary applications of skin penetration enhancersPharmaceutical Skin Penetration EnhancementNew York, NYMarcel Dekker1993
- SantoyoSArellanoAYgartuaPMartinCIn vitro percutaneous absorption of piroxicam through synthetic membranes and abdominal rat skinPharm Acta Helv1996711411468810580
- TanojoHBouwstraJAJungingerHEBoddéHEIn vitro human skin barrier modulation by fatty acids: Skin permeation and thermal analysis studiesPharm Res19971442499034219
- ParkECuiYYunBJKoIJChiSCTransdermal delivery of piroxicam using microemulsionsArch Pharm Res20052824324815789759
- EndoMYamamotoTIjuinTEffect of nonionic surfactants on the percutaneous absorption of tenoxicamChem Pharm Bull1996448658678681419
- OkuyamaHIkedaYKasaiSImamoriKTakayamaKNagaiTInfluence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasmInt J Pharm199918614114810486432
- LópezALlinaresFCortellCHerráezAMComparative enhancer effects of Span® 20 with Tween® 20 and Azone® on the in vitro percutaneous penetration of compounds with different lipophilicitiesInt J Pharm200020213314010915936
- ShinSCChoCWOhIJEffects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skinsInt J Pharm200122219920311427350
- KreilgaardMPedersenEJJaroszewskiJWNMR characterisation and transdermal drug delivery potential of microemulsion systemsJ Control Release20006942143311102682
- TsaiYHHsuLRNaitoSIPercutaneous absorption of piroxicam from ointment bases in rabbitsInt J Pharm1985246178
- HadgraftJPlessisJDGoosenCThe selection of non-steroidal anti-inflammatory agents for dermal deliveryInt J Pharm2000207313711036227
- HadgraftJWaltersKAWottonPKFacilitated percutaneous absorption: A comparison and evaluation of two in vitro modelsInt J Pharm198632257263
- GreenPGHadgraftJFacilitated transfer of cationic drugs across a lipoidal membrane by oleic acid and lauric acidInt J Pharm198737251255
- CheongHAChoiHKEffect of ethanolamine salts and enhancers on the percutaneous absorption of piroxicam from a pressure sensitive adhesive matrixEur J Pharm Sci20031814915312594008
- MurthySNZhaoYLSenAHuiSWCyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporationJ Control Release20049939340215451597
- HillJRWertzPWMolecular models of the intercellular lipid lamellae from epidermal stratum corneumBiochim Biophys Acta2003161612112614561469
- McneillSCPottsROFrancoeurMLLocal enhanced topical delivery (LETD) of drugs: Does it truly existPharm Res19929142214271475228
- HeynemanCALawless-LidayCWallGCOral versus topical NSAIDs in rheumatic diseases: A comparisonDrugs20006055557511030467
- ShargelLWu-PingSYuABCApplied Biopharmaceutics and PharmacokineticsNew York, NYMcGraw-Hill1999
- ShakeelFBabootaSAhujaAAliJAqilMShafiqSNanoemulsions as vehicles for transdermal delivery of aceclofenacAAPS PharmSciTech20078E19
- VeigaAPDuarteIDAvilaMNde MottaPGTatsuoMAFrancischiJNPrevention by celecoxib of secondary hyperalgesia induced by formalin in ratsLife Sci2004752807281715464832
- ZhangYShafferAPortanovaJSeibertKIsaksonPCInhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 productionJ Pharmacol Exp Ther1997283106910769399978